|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/17 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| C07K 19/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Patento numeris | 2233149 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10167232.7 |
| Europos patento paraiškos padavimo data | 2008-10-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-09-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-02-10 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 980331 P | 2007-10-16 | US |
| (72) |
Broly, Herve, FR
Ponce Jr., Rafael A., US
Graffner, Hans Otto Lennart, SE
Peano, Sergio, IT
|
| (73) |
ARES TRADING S.A.,
Zone Industrielle de l`Ouriettaz, 1170 Aubonne,
CH
ZymoGenetics, Inc., 1201 Eastlake Avenue East, Seattle, Washington 98102, US |
| (54) | Combination of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and anti-CD20 agents for treatment of autoimmune disease |
| Combination of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and anti-CD20 agents for treatment of autoimmune disease |